Agios Pharma share price logo

Agios Pharma

NASDAQ: AGIO

Mid Cap

$32.90

-1.29

(-3.77%)

as on

Agios Pharma Stock Performance

as on September 25, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $31.37
    $34.12
    downward going graph

    4.65%

    Downside

    3.71%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $22.24
    $46.00
    downward going graph

    32.40%

    Downside

    39.82%

    Upside

    downward going graph

Agios Pharma share price movements today

Previous Close
$34.19
Open
$34.00
Volume
1.3M
Market Cap
$2.0B
Day's Low - High
$31.37 - $34.12
52 Week Low - High
$22.24 - $46.00

Agios Pharma Historical Returns

1 Month Return
-2.95 %
3 Month Return
-9.12 %
1 Year Return
-10.13 %
3 Year Return
+ 34.78 %
5 Year Return
-30.77 %

Agios Pharma Stock Fundamentals & Key Indicators

Check Agios Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-7.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.88

Industry PE ratio

-15.36

PEG Ratio

0.03050209030992801

EBITDA

-416.8M

Revenue (TTM)

98.3M

Profit Margin

87.92%

Return On Equity TTM

-35.67%

Agios Pharma Stock Valuation

Track how Agios Pharma P/E has moved over time to understand its valuation trends.

Agios Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-6.64x)

December 31, 2022

Industry (-15.36x)

December 31, 2025

Today (-3.82x)

December 31, 2025

Highest (2.77x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -3.82x

Agios Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Agios Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$2.0B-30.77%-4.8887.92%0.00%
Neutral$72.7B-54.71%-22.82-12.57%0.00%
StrongBuy$130.9B184.51%29.8186.04%0.00%
Buy$82.8B24.59%19.1584.86%0.46%

Stock Returns calculator for Agios Pharma Stock including INR - Dollar returns

The Agios Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Agios Pharma investment value today

Current value as on today

₹97,122

Returns

-₹2,878

(-2.88%)

Returns from Agios Pharma Stock

-₹10,134 (-10.13%)

Dollar Impact

₹7,256 (+7.26%)

Analyst Recommendation on Agios Pharma Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Agios Pharma. Average target price of $46.25

Agios Pharma Share Price Target

Get share price movements and forecasts by analysts on Agios Pharma.

What analysts predicted

28.86%UPSIDE

Target Price

$46.25

Current Price

$32.9

Analyzed by

4 Analysts

Target

$46.25

Agios Pharma target price $46.25, a slight upside of 28.86% compared to current price of $32.9. According to 4 analysts rating.

Indian Investors' Interest in Agios Pharma Stock

Search interest for Agios Pharma Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Agios Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
8
8
8
10
8
12
12
19
20
44
Gross Profit
6
5
8
9
6
9
9
16
18
41
Operating Income
-92
-105
-102
-125
-106
-127
-116
-121
-110
-110
EBITDA
-80
-94
1,002
-104
-88
-110
-102
-107
-97
-109
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-81
-96
1,001
-105
-89
-112
-103
-109
-99
-100
Income Tax Expense
-
-
53
-8
-
-
-
-1
-
-
Net Income
-81
-96
947
-96
-89
-112
-103
-108
-99
-100
Net Profit Margin
75.88%
64.16%
91.27%
88.26%
72.92%
76.23%
76.30%
84.25%
87.07%
93.30%

Agios Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
43
94
117
-
-
14
26
36
54
Gross Profit
-249
92
116
-18
-18
12
17
32
42
Operating Income
-320
-362
-426
-335
-378
-389
-391
-425
-472
EBITDA
-314
-338
-394
-310
-337
-223
-345
723
-408
Interest Expense
-
-
-
17
-
-
-
-
-
Depreciation
6
7
16
18
18
8
6
5
5
Income Before Tax
-314
-346
-411
-329
-356
-231
-352
717
-413
Income Tax Expense
-
-
-
-
-
-
-
44
-1
Net Income
-314
-346
-411
-327
1,604
-231
-352
673
-412
Net Profit Margin
-580.48%
98.52%
98.88%
0.00%
0.00%
88.03%
64.57%
88.59%
78.67%

Agios Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-81
-96
947
-96
-89
-112
-103
-108
-99
-100
Operating Cash Flow
-99
-72
-84
-133
-111
-77
-88
-96
-118
-57
Investing Cash Flow
124
37
250
-49
112
78
95
90
141
40
Financing Cash Flow
5
1
2
4
1
0
4
2
2
3
Change in Cash
30
-34
169
-177
2
1
11
-3
24
-13

Agios Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-314
-346
-411
-329
-356
-231
-352
673
-412
Operating Cash Flow
-285
-304
-370
-290
-407
-309
-296
-389
-372
Investing Cash Flow
-57
-273
91
75
1,248
243
239
363
377
Financing Cash Flow
285
546
289
261
-765
2
5
14
8
Change in Cash
-58
-32
10
46
75
-63
-51
-11
12

Mutual Funds that own Agios Pharma Stock

Check out the Mutual Funds with significant holdings in Agios Pharma.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.764336%
4635455
Delaware Group Equity Funds V
6.722855%
4013671
DFA INVESTMENT DIMENSIONS GROUP INC
1.084396%
647405
Fidelity Salem Street Trust
1.0667%
636840
T. ROWE PRICE SMALL-CAP VALUE FUND, INC.
1.020905%
609500

Global Institutional Holdings in Agios Pharma

Funds
Holdings
Andrew J.M. Spokes
9.91%
Vanguard
8.92%
VANGUARD INDEX FUNDS
7.76%
Delaware Group Equity Funds V
6.72%
iShares
4.78%

Agios Pharma News & Key Events

  • img

    Today's Timeline - 24 December

    Wed, 10:37 AM

    -

    Agios Pharmaceuticals announces FDA approval for AQVESME (mitapivat) for anemia in thalassemia, shares fell 1.4% to $24.59.

    Wed, 06:01 PM

    -

    Agios shares rise 9.80% to $27.00 premarket after FDA approval of AQVESME for thalassemia-related anemia.

    Wed, 06:48 PM

    -

    FDA expands approval for mitapivat, expected to generate $320 million additional peak revenue opportunity.

  • img

    Today's Timeline - 24 December

    Wed, 10:33 PM

    -

    Management outlines marketing plans for AQVESME, targeting 4,000 patients with a price of $425,000 annually.

Insights on Agios Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 8.72M → 44.74M (in $), with an average increase of 25.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 701.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 98.5% return, outperforming this stock by 63.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, AGIO stock has moved down by -2.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -99.11M → -100.70M (in $), with an average decrease of 1.6% per quarter

About Agios Pharma

Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.
OrganisationAgios Pharma
Headquarters88 Sidney Street, Cambridge, MA, 02139, US
IndustryBiotechnology
CEOBrian Goff
E-voting on sharesClick here to vote

Key Management of Agios Pharma

Name

Title

Ms. Cecilia Jones

Chief Financial Officer

Mr. James William Burns

Chief Legal Officer

Dr. Lewis clayton Cantley Ph.D.

Co-Founder

Dr. Shin-San Su Ph.D.

Co-Founder

Mr. Brian M. Goff M.B.A.

CEO & Director

Dr. Krishnan Viswanadhan M.B.A., Pharm.D.

Chief Strategy & Operations Officer

Dr. Sarah Gheuens M.D., Ph.D.

Chief Medical Officer and Head of Research & Development

Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.

Co-Founder

Dr. Craig B. Thompson M.D.

Co-Founder

Mr. T. J. Washburn

VP, Controller & Principal Accounting Officer

FAQs

What is Agios Pharma share price today?

Agios Pharma share price today is $32.90 as on at the close of the market. Agios Pharma share today touched a day high of $34.12 and a low of $31.37.

What is the 52 week high and 52 week low for Agios Pharma share?

Agios Pharma share touched a 52 week high of $46.00 on and a 52 week low of $22.24 on . Agios Pharma stock price today i.e. is closed at $32.90,which is 28.48% down from its 52 week high and 47.93% up from its 52 week low.

What is Agios Pharma's market capitalisation today?

Agios Pharma market capitalisation is $0.00T as on .

How to invest in Agios Pharma Stock (AGIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Agios Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agios Pharma Shares that will get you 0.0456 shares as per Agios Pharma share price of $32.90 per share as on September 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy Agios Pharma Stock (AGIO) from India?

Indian investors can start investing in Agios Pharma (AGIO) shares with as little as ₹95.945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.45 in Agios Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Agios Pharma share’s latest price of $32.90 as on September 25, 2026 at 8:45 am IST, you will get 0.3040 shares of Agios Pharma. Learn more about fractional shares .

What are the returns that Agios Pharma has given to Indian investors in the last 5 years?

Agios Pharma stock has given -30.77% share price returns and 29.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?